novel aromatic heterocyclic compounds inhibit cytokines production involved in immunoregulation and inflammation such as interleukin - 1 and tumor necrosis factor production . the compounds are therefore useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases .